In this four-part series, Ines Tenente (Senior Consultant – Global Market Access) explores the various challenges facing orphan medicines entering the European market and suggests solutions that can help improve...
Read More
Challenges for orphan medicines entering the European market – Part 3: Economic evidence development
In this four-part series, Ines Tenente (Senior Consultant – Global Market Access) explores the various challenges facing orphan medicines entering the European market and suggests solutions that can help improve patient...
Read More
Challenges for orphan medicines entering the European market – Part 2: Clinical evidence development
In this four-part series, Ines Tenente (Senior Consultant – Global Market Access) explores the various challenges facing orphan medicines entering the European market and suggests solutions that can help improve patient...
Read More
In this four-part series, Ines Tenente (Senior Consultant – Global Market Access) explores the various challenges facing orphan medicines entering the European market and suggests solutions that can help improve...
Read More
Guest author Professor Fabrizio Gianfrate shares his thoughts on how spending priorities have shifted in the pandemic, how they may further evolve in a post-COVID era, and how European agencies...
Read More
Mtech Access attended the virtual World Pharma Pricing Market Access & Evidence Congress on 23–25th September 2020, where our team were inspired by the range of seminars, round tables and...
Read More
Inês M Tenente shares what drives her passion for market access, why she chose to join the Mtech Access Global Market Access team and what she has experienced in the...
Read More
We are delighted to announce that Mtech Access has been accepted as a corporate member of the British Healthcare Business Intelligence Association (BHBIA). At Mtech Access, we support our pharma...
Read More
Each year, on 11th February, the United Nations and the global scientific community celebrate the International Day of Women and Girls in Science. Women are underrepresented in science and are...
Read More
We understand that the path to successful global market access and uptake is complex and multi-faceted. Defining robust pricing and market access strategies, and developing meaningful value strategies, are essential...
Read More